Literature DB >> 29846773

Electromagnetic navigation-guided neuroendoscopic transfrontal transaqueductal fenestration of expansive posterior fossa arachnoid cyst with simultaneous endoscopic third ventriculostomy in an infant.

Petr Liby1, V L Torres2, J Taborsky3, M Kyncl4, M Tichy3.   

Abstract

INTRODUCTION: We present an infant with an expansive posterior fossa arachnoid cyst and severe clinical deterioration due to decompensated obstructive hydrocephalus. Given the dilated Sylvius aqueduct, we favoured the endoscopic transfrontal transaqueductal route to approach the cyst. CASE REPORT: A 12-month-old boy was acutely admitted for severe symptoms of intracranial hypertension. Imaging revealed spacious cystic formation in the posterior fossa with expansive behaviour towards the brain stem, fourth ventricle and cerebellum associated with obstructive triventricular hydrocephalus. The patient underwent electromagnetically navigated transfrontal transaqueductal cyst fenestration with simultaneous ETV from two precoronal trajectories with a rigid endoscope.
CONCLUSION: A transaqueductal approach with a rigid endoscope is rarely published, and we were amazed by the impact on the child's clinical improvement after this minimally invasive endoscopic procedure. The case is well documented with imaging and perioperative neuroendoscopic views.

Entities:  

Keywords:  Electromagnetic neuronavigation; Endoscopic third ventriculostomy; Neuroendoscopy; Posterior fossa cyst; Transaqueductal fenestration

Mesh:

Year:  2018        PMID: 29846773     DOI: 10.1007/s00381-018-3847-1

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  9 in total

1.  Endoscopic opening of the foramen of magendie using transaqueductal navigation for membrane obstruction of the fourth ventricle outlets. Technical note.

Authors:  Pierluigi Longatti; Alessandro Fiorindi; Alberto Feletti; Vittorio Baratto
Journal:  J Neurosurg       Date:  2006-12       Impact factor: 5.115

2.  Endoscopic transaqueductal removal of fourth ventricular neurocysticercosis with an angiographic catheter.

Authors:  Mazhar Husain; Manu Rastogi; Deepak K Jha; Nuzhat Husain; Rakesh K Gupta
Journal:  Neurosurgery       Date:  2007-04       Impact factor: 4.654

3.  Arachnoid cyst of the fourth ventricle and "arrested" hydrocephalus.

Authors:  C Di Rocco; G Di Trapani; A Iannelli
Journal:  Surg Neurol       Date:  1979-12

4.  Endoscopic aqueductoplasty: technique and results.

Authors:  H W Schroeder; M R Gaab
Journal:  Neurosurgery       Date:  1999-09       Impact factor: 4.654

5.  Endoscopic aqueductoplasty in the treatment of aqueductal stenosis.

Authors:  Henry W S Schroeder; Joachim Oertel; Michael R Gaab
Journal:  Childs Nerv Syst       Date:  2004-07-08       Impact factor: 1.475

6.  Primary obstruction of the fourth ventricle outlets: neuroendoscopic approach and anatomic description.

Authors:  Pierluigi Longatti; Alessandro Fiorindi; Andrea Martinuzzi; Alberto Feletti
Journal:  Neurosurgery       Date:  2009-12       Impact factor: 4.654

Review 7.  A different approach to cysts of the posterior fossa.

Authors:  Marvin D Nelson; Karima Maher; Floyd H Gilles
Journal:  Pediatr Radiol       Date:  2004-07-30

Review 8.  Transventricular, transaqueductal scope-in-scope endoscopic excision of fourth ventricular neurocysticercosis: a series of 13 cases and a review.

Authors:  Ashish Suri; Rohit Kumar Goel; Faiz Uddin Ahmad; Ananth Kesav Vellimana; Bhawani Shankar Sharma; Ashok Kumar Mahapatra
Journal:  J Neurosurg Pediatr       Date:  2008-01       Impact factor: 2.375

9.  Endoscopic transventricular transaqueductal Magendie and Luschka foraminoplasty for hydrocephalus.

Authors:  Jaime Torres-Corzo; Juan Sánchez-Rodríguez; Dominic Cervantes; Roberto Rodríguez-Della Vecchia; Fernando Muruato-Araiza; Steven W Hwang; Leonardo Rangel-Castilla
Journal:  Neurosurgery       Date:  2014-04       Impact factor: 4.654

  9 in total
  1 in total

Review 1.  Telovelar surgical approach.

Authors:  Michael G Z Ghali
Journal:  Neurosurg Rev       Date:  2019-12-05       Impact factor: 3.042

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.